{"Title": "Targeted Treatment in Childhood Epilepsy Syndromes", "Year": 2016, "Source": "Curr. Treat. Options Neurol.", "Volume": "18", "Issue": 6, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 5, "DOI": "10.1007/s11940-016-0407-4", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84966350052&origin=inward", "Abstract": "\u00a9 2016, The Author(s).The mainstay of treatment of epilepsy has been antiepileptic drugs; however, despite the emergence of new agents, a consistent proportion remain drug-resistant. Newer AEDs show promise. However, as it becomes clear that the epilepsies are a group of diseases rather than a single disorder the prospect of targeted treatment in some may become a reality.", "AuthorKeywords": ["Antiepileptic drugs (AED)", "Cannabidiol (CBD)", "Childhood epilepsies", "Epileptic encephalopathy", "Ketogenic diet (KD)", "Next generation sequencing (NGS)", "Targeted therapy"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84966350052", "SubjectAreas": [["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"56347087500": {"Name": "Cross J.H.", "AuthorID": "56347087500", "AffiliationID": "60018207", "AffiliationName": "Great Ormond Street Hospital for Children NHS Trust"}, "16308421500": {"Name": "Vezyroglou K.", "AuthorID": "16308421500", "AffiliationID": "60018207", "AffiliationName": "Great Ormond Street Hospital for Children NHS Trust"}}}